Public-Private Banking Leverage Cryo-Cell’s dual model as the world’s first private cord blood bank with an established public banking program in partnership with Duke University to position cross-selling opportunities for families considering cryopreservation and potential public donations.

Regulatory & Quality Highlight Cryo-Cell’s robust quality credentials (FDA-registered, cGMP/cGTP-compliant, AABB, FACT accreditation, ISO 13485) to reassure clinical customers and hospital partners about compliance, quality of stem cell processing, and reliability for referrals.

Accreditations as Leverage Utilize FACT accreditation longevity and ISO certification to pitch to healthcare systems and insurers as a differentiator when promoting contract processing, storage, and potential research collaborations in regenerative medicine.

Expansion & Partnerships The national footprint with cord blood donation sites across major hospitals presents opportunities to cross-sell storage services to obstetricians, maternity centers, and hospital networks seeking integrated family bank and donation workflows.

Public Market Signals Share recent compliance plan advancements with NYSE American and steady revenue base to investors and partners, framing Cryo-Cell as a stable long-term partner for hospital systems and research institutions pursuing scalable cord blood programs.